Analysts at Lake Street Capital began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Get Free Report) in a report issued on Wednesday,Briefing.com Automated Import reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. Lake Street Capital’s target price points to a potential upside of 247.83% from the company’s previous close.
Several other brokerages also recently weighed in on AVR. Barclays assumed coverage on shares of Anteris Technologies Global in a research report on Tuesday. They set an “overweight” rating and a $22.00 price objective for the company. TD Cowen began coverage on shares of Anteris Technologies Global in a research report on Tuesday. They issued a “buy” rating and a $15.00 price target for the company. Finally, Cantor Fitzgerald started coverage on shares of Anteris Technologies Global in a research note on Tuesday. They issued an “overweight” rating and a $9.00 price objective for the company.
Check Out Our Latest Stock Analysis on AVR
Anteris Technologies Global Stock Performance
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- What Are Treasury Bonds?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- The Basics of Support and Resistance
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
- What Are Dividend Contenders? Investing in Dividend Contenders
- Cal-Maine Foods: A Defensive Play With a Cage-Free Future
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
